Related Experiment Video
Updated: Jul 27, 2026
11:24
Direct Protein Delivery to Mammalian Cells Using Cell-permeable Cys2-His2 Zinc-finger Domains
Published on: March 25, 2015
Synthetic peptide-based DNA complexes for nonviral gene delivery
1Baylor College of Medicine, Department of Medicine, The Methodist Hospital, MS A-601 6565 Fannin St., Houston, TX 77030-3498, USA
Advanced Drug Delivery Reviews
|June 6, 2000
Summary
Synthetic peptide-based DNA delivery systems offer flexible, non-viral gene delivery. These systems avoid viral biohazards and gene size limitations, enabling potential repeated administration for targeted gene therapy.
Area of Science:
- Biotechnology
- Molecular Biology
- Gene Therapy
Background:
- Synthetic peptide-based DNA delivery systems offer an alternative to viral vectors.
- Viral vectors present challenges including biohazards and limitations on gene insert size.
Purpose of the Study:
- To highlight the advantages of synthetic peptide-based DNA delivery systems.
- To discuss their flexibility, safety, and potential for therapeutic applications.
Main Methods:
- Modification of synthetic peptide composition for optimized DNA complex formation.
- In vitro and in vivo experimentation to assess delivery efficiency and barriers.
Main Results:
- Synthetic systems avoid heterogeneity issues seen with DNA-poly(L-lysine) interactions.
- These systems bypass viral genome-related biohazards and vector production requirements.
- No limitations on the size of therapeutic genes for delivery.
Conclusions:
- Synthetic peptide-based DNA delivery systems provide a flexible and safe platform for gene therapy.
- Their potential for repeated administration makes them promising for in vivo gene targeting.
Related Concept Videos
01:09Recombinant DNA
Overview
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...